You are here
- Home
- Drug Products
- All Drug Products
An Open-label, sequential, 3-period study to Assess the Effects of Diltiazem on the Pharmacokinetics of Naloxegol in Healthy Subjects.
- Disease
- pharmacokinetics
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Generic Name
- Naloxegol
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D3820C00032
- Study Id
- D3820C00032
- ClinicalTrials.gov ID
- NCT01594619
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
